{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:35:16Z","timestamp":1789504516640,"version":"build-2803163510"},"reference-count":39,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>People with opioid use disorder (OUD) in prison face an acute risk of death after release. We estimated whether prison\u2010based opioid substitution treatment (OST) reduces this risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Prospective observational cohort study using prison health care, national community drug misuse treatment and deaths registers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Recruitment at 39 adult prisons in England (32 male; seven female) accounting for 95% of OST treatment in England during study planning.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>\n                      Adult prisoners diagnosed with OUD (recruited: September 2010\u2013August 2013; first release: September 2010; last release: October 2014; follow\u2010up to February 2016;\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a015\u2009141 in the risk set).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention and Comparator<\/jats:title>\n                    <jats:p>\n                      At release, participants were classified as OST exposed (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a08645) or OST unexposed (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a06496). The OST unexposed group did not receive OST, or had been withdrawn, or had a low dose.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements<\/jats:title>\n                    <jats:p>Primary outcome: all\u2010cause mortality (ACM) in the first 4\u00a0weeks. Secondary outcomes: drug\u2010related poisoning (DRP) deaths in the first 4\u00a0weeks; ACM and DRP mortality after 4\u00a0weeks to 1\u00a0year; admission to community drug misuse treatment in the first 4\u00a0weeks. Unadjusted and adjusted Cox regression models (covariates: sex, age, drug injecting, problem alcohol use, use of benzodiazepines, cocaine, prison transfer and admission to community treatment), tested difference in mortality rates and community treatment uptake.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>During the first 4\u00a0weeks after prison release there were 24 ACM deaths: six in the OST exposed group and 18 in the OST unexposed group [mortality rate 0.93 per 100 person\u2010years (py) versus 3.67 per 100 py; hazard ratio (HR)\u00a0=\u00a00.25; 95% confidence interval (CI)\u00a0=\u00a00.10\u20130.64]. There were 18 DRP deaths: OST exposed group mortality rate 0.47 per 100 py versus 3.06 per 100 py in the OST unexposed group (HR\u00a0=\u00a00.15; 95% CI\u00a0=\u00a00.04\u20130.53). There was no group difference in mortality risk after the first month. The OST exposed group was more likely to enter drug misuse treatment in the first month post\u2010release (odds ratio 2.47, 95% CI\u00a0=\u00a02.31\u20132.65). The OST mortality protective effect on ACM and DRP mortality risk was not attenuated by demographic, overdose risk factors, prison transfer or community treatment (fully adjusted HR\u00a0=\u00a00.25; 95% CI\u00a0=\u00a00.09\u20130.64 and HR\u00a0=\u00a00.15; 95% CI\u00a0=\u00a00.04\u20130.52, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In an English national study, prison\u2010based opioid substitution therapy was associated with a 75% reduction in all\u2010cause mortality and an 85% reduction in fatal drug\u2010related poisoning in the first month after release.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/add.13779","type":"journal-article","created":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T02:22:42Z","timestamp":1486174962000},"page":"1408-1418","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":166,"title":["Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England"],"prefix":"10.1111","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1307-2498","authenticated-orcid":false,"given":"John","family":"Marsden","sequence":"first","affiliation":[{"name":"Addictions Department, Institute of Psychiatry Psychology and Neuroscience, King's College London, London  UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry","family":"Stillwell","sequence":"additional","affiliation":[{"name":"Addictions Department, Institute of Psychiatry Psychology and Neuroscience, King's College London, London  UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Jones","sequence":"additional","affiliation":[{"name":"School of Social and Community Medicine, Faculty of Health Sciences University of Bristol, Bristol  UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha","family":"Cooper","sequence":"additional","affiliation":[{"name":"Alcohol, Drug and Tobacco Division Health and Wellbeing Directorate, Public Health England  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Eastwood","sequence":"additional","affiliation":[{"name":"Alcohol, Drug and Tobacco Division Health and Wellbeing Directorate, Public Health England  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Farrell","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre University of New South Wales  New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Lowden","sequence":"additional","affiliation":[{"name":"Alcohol, Drug and Tobacco Division Health and Wellbeing Directorate, Public Health England  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nino","family":"Maddalena","sequence":"additional","affiliation":[{"name":"Alcohol, Drug and Tobacco Division Health and Wellbeing Directorate, Public Health England  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Metcalfe","sequence":"additional","affiliation":[{"name":"School of Social and Community Medicine, Faculty of Health Sciences University of Bristol, Bristol  UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Shaw","sequence":"additional","affiliation":[{"name":"Institute of Brain, Behaviour and Mental Health University of Manchester, Manchester  UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hickman","sequence":"additional","affiliation":[{"name":"School of Social and Community Medicine, Faculty of Health Sciences University of Bristol, Bristol  UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,3,1]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61138-0"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01495.x"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.12.108282"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1999.9479612.x"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.11.018"},{"key":"e_1_2_9_7_1","unstructured":"Office for National Statistics.Statistical bulletin: deaths related to drug poisoning in England and Wales: registrations;2015. Available at:http:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/bulletins\/deathsrelatedtodrugpoisoninginenglandandwales\/2015registrations(accessed 30 January 2017) (Archived athttp:\/\/www.webcitation.org\/6ntic0Z90)."},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01316.x"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.02081.x"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.02990.x"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12010"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2015.201"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2225"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v24n01_05"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_2_9_16_1","unstructured":"World Health Organization.International classification of diseases;2007 10th edn (ICD\u201010). Available at:http:\/\/www.who.int\/classifications\/apps\/icd\/icd10online\/(accessed 30 January 2017) (Archived athttp:\/\/www.webcitation.org\/6ntipvNyx)."},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002207.pub4"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e5945"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13193"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12971"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61420-3"},{"key":"e_1_2_9_22_1","first-page":"117","article-title":"Introduction of the integrated drug treatment system (IDTS) in English prisons","volume":"6","author":"Marteau D.","year":"2010","journal-title":"Int J Prison Health"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61420-3"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03676.x"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X"},{"key":"e_1_2_9_26_1","unstructured":"National Institute for Health and Care Excellence (NICE).Methadone and buprenorphine for the management of opioid dependence. NICE technology appraisal guidance [TA114]. Available at:https:\/\/www.nice.org.uk\/guidance\/TA114\/chapter\/About\u2010this\u2010guidance(accessed 30 January 2017) (Archived athttp:\/\/www.webcitation.org\/6ntj6F7gs)."},{"key":"e_1_2_9_27_1","unstructured":"Office for National Statistics. Available at:http:\/\/www.ons.gov.uk\/ons\/rel\/subnational\u2010health3\/deaths\u2010related\u2010to\u2010drug\u2010poisoning\/england\u2010and\u2010wales\u2010\u2010\u20102013\/stb\u2010\u2010\u2010deaths\u2010related\u2010to\u2010drug\u2010poisoning\u2010in\u2010england\u2010and\u2010wales\u2010\u20102013.html#tab\u2010background\u2010notes(accessed 30 January 2017) (Archived athttp:\/\/www.webcitation.org\/6ntjD3rCb)."},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.02025.x"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.01.020"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-4348-9"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3618"},{"key":"e_1_2_9_32_1","volume-title":"Statistical Analysis with Missing Data","author":"Little R. J. A.","year":"1987"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/68.2.373"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12536"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b5087"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12969"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12107"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13265"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12894"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2015.07.005"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadd.13779","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.13779","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/add.13779","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.13779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:15:25Z","timestamp":1780982125000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.13779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,1]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1111\/add.13779"],"URL":"https:\/\/doi.org\/10.1111\/add.13779","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,1]]},"assertion":[{"value":"2016-11-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-02-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}